1. Evaluating the organization and delivery of breast cancer services: use of performance measures to identify knowledge gaps

   • A. Gagliardi
   • F. C. Wright
   • D. McCready

   Review 01 November 2006 Pages: 131 - 148

   

2. Hormonal therapy for postmenopausal breast cancer: the science of sequencing

   • William R. Miller
   • John M. S. Bartlett
   • Mark Verrill

   Review 13 October 2006 Pages: 149 - 160

   

3. Polymorphisms of the DNA polymerase β gene in breast cancer

   • Tomasz Sliwinski
   • Pawel Ziemba
   • Janusz Blasiak

   Preclinical Study 28 November 2006 Pages: 161 - 166

4. Hypoxia-inducible factor-1α correlates with MET and metastasis in node-negative breast cancer

   • Helen H. W. Chen
   • Wu-Chou Su
   • Wen-Ying Lee

   PRECLINICAL STUDY 21 September 2006 Pages: 167 - 175

   

5. A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

   • Janice M. Walshe
   • Arlene W. Berman
   • Sandra M. Swain

   CLINICAL TRAIL 13 October 2006 Pages: 177 - 183

   

6. Breast cancer patients on adjuvant chemotherapy report a wide range of problems not identified by health-care staff

   • Mogens Groenvold
   • Peter M. Fayers
   • Henning T. Mouridsen

   CLINICAL TRIAL 13 October 2006 Pages: 185 - 195

   

7. Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue

   • Lida Mina
   • Sharon E. Soule
   • Kathy D. Miller

   Clinical trial 13 October 2006 Pages: 197 - 208

   

8. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population

   • Sandra Costa
   • Daniela Pinto
   • Fernando Schmitt

   Epidemiology 25 October 2006 Pages: 209 - 217

   

9. Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case–control study

   • P. Soucek
   • T. Borovanova
   • J. Novotny

   Epidemiology 13 October 2006 Pages: 219 - 224

10. High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia

    • Diana Torres
    • Muhammad Usman Rashid
    • Ute Hamann

    Epidemiology 02 November 2006 Pages: 225 - 232

    

11. Breast cancer incidence trends in deprived and affluent Scottish women

    • Sylvia B. F. Brown
    • David J. Hole
    • Timothy G. Cooke

    ORIGINAL PAPER 11 October 2006 Pages: 233 - 238

    

12. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7

    • Emma-Leena Alarmo
    • Tuula Kuukasjärvi
    • Anne Kallioniemi

    ORIGINAL PAPER 21 September 2006 Pages: 239 - 246

    

13. Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors

    • Marketa Brozova
    • Zdenek Kleibl
    • Eva Matouskova

    OriginalPaper 25 October 2006 Pages: 247 - 257